[Pulmonary endarterectomy--the surgical treatment of chronic thromboembolic pulmonary hypertension]

J Lindner1, P Jansa, J Kunstýr

  • 1II. chirurgická klinika kardiovaskulární chirurgie 1, LF UK a VFN, Praha. lindner@seznam.cz

Casopis Lekaru Ceskych
|April 28, 2006
PubMed

Insights

Pulmonary endarterectomy (PEA) offers a life-saving treatment for chronic thromboembolic pulmonary hypertension (CTEPH). This surgical intervention significantly improves patient survival and pulmonary function.

Area of Science:

  • Cardiovascular Surgery
  • Pulmonary Hypertension Research
  • Medical Innovation

Context:

  • Chronic thromboembolic pulmonary hypertension (CTEPH) presents a poor prognosis without effective treatment.
  • Pulmonary artery endarterectomy (PEA) was introduced in the Czech Republic in 2004.
  • Established collaboration with international experts in PEA.

Purpose:

  • To implement and evaluate the efficacy of pulmonary artery endarterectomy (PEA) for surgically treatable CTEPH.
  • To establish a specialized program for the complex diagnosis and treatment of CTEPH patients.

Summary:

  • A modified reverse endarterectomy technique using deep hypothermic circulatory arrest was employed.
  • Twelve CTEPH patients underwent surgery with zero mortality by September 2005.
  • Significant improvements in hemodynamic parameters and 6-minute walking distance were observed post-surgery.

Impact:

  • PEA is a viable treatment for CTEPH with surgically accessible obstruction.
  • Centralized patient care enhances expertise in managing complex CTEPH cases.
  • Multidisciplinary collaboration is crucial for successful CTEPH treatment programs.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...